Brief: Spectrum Pharma Announces Debt Financing Agreement With SLR Capital Partners
23/09/2022 12:16
Sept 23 (Reuters) - Spectrum Pharmaceuticals Inc
SPPI.O :
* SPECTRUM PHARMACEUTICALS ANNOUNCES DEBT FINANCING
AGREEMENT WITH
SLR CAPITAL PARTNERS WITH $30 MILLION FUNDED AT CLOSING
* SPECTRUM PHARMACEUTICALS INC - CASH RUNWAY EXTENDED
THROUGH 2024
* SPECTRUM PHARMACEUTICALS INC - FUNDING PROVIDES ADDITIONAL
CAPITAL TO OPTIMIZE COMMERCIAL LAUNCH OF ROLVEDON
* SPECTRUM PHARMACEUTICALS INC - MULTIPLE TRANCHE DEBT
FINANCING
PROVIDES SPECTRUM WITH UP TO $65 MILLION
* SPECTRUM PHARMACEUTICALS INC - SPECTRUM WILL HAVE ACCESS
TO UP
TO $65 MILLION IN DEBT FINANCING, DIVIDED INTO FOUR TRANCHES
* SPECTRUM PHARMACEUTICALS INC - TRANCHES ARE AVAILABLE FOR
DRAWDOWN AT SPECTRUM'S DISCRETION AT VARIOUS POINTS UNTIL
NOVEMBER 15, 2023
Source text for Eikon: ID:nBw9cK5j5a
Further company coverage: SPPI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectrum Pharmaceuticals
See all newsBrief: Assertio Holdings Announces Favorable Vote On Proposed Acquisition Of Spectrum Pharmaceuticals
Brief: Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “For” Proposed Deal With Assertio Holdings, Inc.
Brief: Spectrum Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary